Home › Funds › Palo Alto Investors LP › ACRS
Palo Alto Investors LP position in ACRS
ACLARIS THERAPEUTICS INC · Health Care
Palo Alto Investors LP reported holding 1,156,396 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$6.1M, representing 0.90% of its reported portfolio and ranking #26 among its reported holdings. Palo Alto Investors LP has disclosed ACRS holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's ACRS position evolved
Palo Alto Investors LP first disclosed a stake in ACRS in Q1 2024 at 569,832 shares (US$707K). The position peaked in Q2 2026 at 1,613,430 shares, worth US$8.5M. Across 11 filings, Palo Alto Investors LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 1,156,396 shares valued at US$6.1M — a reduction of -457,034 shares quarter over quarter.. Notable position changes include a 36% increase in Q1 2025 (shares fell 7% over the following quarter), a 79% increase in Q2 2025 (shares rose 34% over the following quarter), a 28% trim in Q3 2026 (shares fell 31% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 569.83K | $706.59K | New |
| Q2 2024 | 569.83K | $626.82K | Hold |
| Q3 2024 | 569.83K | $655.31K | Hold |
| Q4 2024 | 569.83K | $1.41M | Hold |
| Q1 2025 | 776.03K | $1.19M | Add |
| Q2 2025 | 1.39M | $1.97M | Add |
| Q3 2025 | 1.57M | $2.98M | Add |
| Q4 2025 | 1.57M | $4.72M | Hold |
| Q1 2026 | 1.61M | $6.05M | Add |
| Q2 2026 | 1.61M | $8.54M | Hold |
| Q3 2026 | 1.16M | $6.08M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ACRS and 13F data
ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$66.9M), BML Capital Management, LLC (US$57.6M), Deep Track Capital, LP (US$49.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACRS
- RA CAPITAL MANAGEMENT, L.P. 12.72M sh · $66.92M · Q3 2026
- BML Capital Management, LLC 10.96M sh · $57.62M · Q3 2026
- Deep Track Capital, LP 9.35M sh · $49.15M · Q3 2026
- Frazier Life Sciences Management, L.P. 8.73M sh · $45.92M · Q3 2026
- Vivo Capital, LLC 6.69M sh · $35.21M · Q3 2026
- MPM BioImpact LLC 5.18M sh · $27.24M · Q3 2026
- Decheng Capital LLC 4.04M sh · $21.26M · Q3 2026
- Rock Springs Capital Management LP 3.79M sh · $19.94M · Q3 2026
- Jones Hill Capital LP 2.50M sh · $13.17M · Q3 2026
- STEMPOINT CAPITAL LP 2.05M sh · $10.79M · Q3 2026
- Kalehua Capital Management LLC 1.83M sh · $9.64M · Q3 2026
- Cormorant Asset Management, LP 1.75M sh · $9.21M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held ACRS?
Palo Alto Investors LP has disclosed ACRS holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Palo Alto Investors LP's current position in ACRS?
As of Q3 2026, Palo Alto Investors LP holds 1.16M shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $6.08M, representing 0.90% of its reported portfolio and ranking #26.
Has Palo Alto Investors LP been buying or selling ACRS?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in ACRS. The position peaked in Q2 2026 at 1.61M shares.
Which other funds hold ACRS?
Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.